Asthma UK   Report issue

Academic/Hospital Phase 3
Founded: London United Kingdom (1927)

Organization Overview

First Clinical Trial
2005
NCT00126048
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

atorvastatin (lipitor) (1 trial)

Drugs in Other Trials (2)

budesonide (rhinocort) (1 trial)

citalopram (celexa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3